Concordance assessment of Watson for Oncology in breast cancer chemotherapy: first China experience

BACKGROUND: IBM Watson for Oncology (WFO) is an artificial intelligence cognitive computing system that provides confidence-ranked, evidence-based treatment recommendations for cancer. We examine the level of agreement for breast cancer chemotherapy between WFO recommended and clinical use in a larg...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Hong, Tao, Jing, Qian, Mengjia, Zhou, Wenbin, Qian, Yi, Xie, Hui, Jing, Shengqi, Xu, Tingyu, Zhang, Xin, Dai, Zuolei, You, Mingliang, Liu, Yun, Liu, Xiaoan, Wang, Shui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798315/
https://www.ncbi.nlm.nih.gov/pubmed/35116771
http://dx.doi.org/10.21037/tcr.2019.01.34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798315/
https://www.ncbi.nlm.nih.gov/pubmed/35116771
http://dx.doi.org/10.21037/tcr.2019.01.34

Ejemplares similares